Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient

Multiple Sclerosis

COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment

Mult Scler.

Dersch R, Wehrum T, Fähndrich S, Engelhardt M, Rauer S, Berger B

doi: 10.1177/1352458520943783.

Multiple Sclerosis

Onset of secondary progressive MS after long-term rituximab therapy - a case report.

Ann Clin Transl Neurol.

von Büdingen HC, Bischof A, Eggers EL, Wang S, Bevan CJ, Cree BA, Henry RG, Hauser SL

doi: 10.1002/acn3.377.

Multiple Sclerosis

Cryptococcal meningoencephalitis in an IgG₂-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report

BMC Neurol.

Wienemann T, Müller AK, MacKenzie C, Bielor C, Weyers V, Aktas O, Hartung HP, Kremer D

doi: 10.1186/s12883-020-01741-0.

Multiple Sclerosis

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report

doi: 10.1055/s-0043-124756.

Multiple Sclerosis

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

Mult Scler.

Boffa G, Sbragia E, Raiola AM, Varaldo R, Capello E, Gallo P, Granella F, Mancardi G, Inglese M

doi: 10.1177/1352458520914818.

Multiple Sclerosis

Early predictors of rapidly evolving multiple sclerosis: A case report

J Neuroimmunol.

Fernando KTM, James M

doi: 10.1016/

Multiple Sclerosis

Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment

Mult Scler.

Graf J, Ringelstein M, Lepka K, Schaller J, Quack H, Hartung HP, Aktas O, Albrecht P

doi: 10.1177/1352458518771276.

Migraine and Headache

Headache as the Presenting Symptom in 2 Patients with COVID-19 and a History of Migraine: 2 Case Reports

Headache.

Singh J, Ali A

doi: 10.1111/head.13890.

Multiple Sclerosis

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report

Mult Scler Relat Disord.

Lapucci C, Gualandi F, Mikulska M, Palmeri S, Mancardi G, Uccelli A, Laroni A

doi: 10.1016/j.msard.2018.09.006.

Related content

COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment

Onset of secondary progressive MS after long-term rituximab therapy - a case report.

Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

Early predictors of rapidly evolving multiple sclerosis: A case report

Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment

Headache as the Presenting Symptom in 2 Patients with COVID-19 and a History of Migraine: 2 Case Reports

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report

Cryptococcal meningoencephalitis in an IgG₂-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report